Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.
- DOI
- 10.1016/j.esmoop.2026.108369
- Published
- 2026 Sep 8
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108369,
title = {Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.},
author = {Farinea G and Mogavero A and Vitale A and Roca E and Scotti V and Delmonte A and Veccia A and Reale ML and Bironzo P and Genova C and Galetta D and Bulotta A and Grossi F and Cortinovis D and Novello S and Bria E and Passiglia F},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2026.108369},
url = {https://doi.org/10.1016/j.esmoop.2026.108369}
}RIS
TY - JOUR TI - Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database. AU - Farinea G AU - Mogavero A AU - Vitale A AU - Roca E AU - Scotti V AU - Delmonte A AU - Veccia A AU - Reale ML AU - Bironzo P AU - Genova C AU - Galetta D AU - Bulotta A AU - Grossi F AU - Cortinovis D AU - Novello S AU - Bria E AU - Passiglia F PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2026.108369 UR - https://doi.org/10.1016/j.esmoop.2026.108369 ER -
APA
G, F., A, M., A, V., E, R., V, S., A, D., A, V., ML, R., P, B., C, G., D, G., A, B., F, G., D, C., S, N., E, B., & F, P. (2026). Osimertinib in advanced non-small cell lung cancer (NSCLC) harboring different EGFR uncommon variants: real-world data from the Italian biomarker ATLAS database.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.108369
Source records
- pubmed · retrieved 2026-09-26T15:15:33.830Z